In this week's issue for #EULAR2019: Upadacitinib as monotherapy in patients with active #rheumatoidarthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study https://t.co/hyAKuBPVtJ https://t.co/xSnHZFZtKo